What Is Preventing Your Organization from Adopting Cardiac PET?
Cardiac PET may offer clear clinical and operational advantages for appropriate cardiovascular imaging programs, depending on patient population, workflow, available resources, and program goals. Yet for many practices, the decision to launch a Cardiac PET program is not only clinical. It also requires careful consideration of operational readiness, financial planning, logistics, and long-term program strategy.
Even when leadership recognizes the value of Cardiac PET, implementation can feel complex. Questions around equipment cost, staffing, workflow, reimbursement, space, regulations, radiopharmaceutical access, and patient volume can slow decision-making before a program ever reaches the planning stage.
The good news is that these barriers are not necessarily reasons to delay adoption. With the right pathway and support, organizations can evaluate Cardiac PET more confidently and build a program designed around their actual goals, resources, and growth potential.
How Can Organizations Manage the Cost of Launching a Cardiac PET Program?
One of the most common barriers to Cardiac PET implementation is the perceived cost of entry. Purchasing dedicated equipment can require significant capital investment. Facilities may also need to account for room buildout, shielding, structural requirements, IT integration, service, maintenance, and ongoing operational expenses.
This is where a flexible access model becomes important. Not every organization needs to begin with a fully permanent, custom-built Cardiac PET suite. Some programs may benefit from a phased approach that allows them to assess demand, establish referral patterns, and increase volume before committing to a larger capital project.
By aligning the Cardiac PET pathway with the organization's current readiness, decision-makers can reduce financial risk while still advancing program development.
What Does Radiopharmaceutical Access Mean for Your Cardiac PET Workflow?
Cardiac PET availability depends on reliable access to radiopharmaceuticals. For programs that offer Rubidium-82, that means managing generator logistics, scheduling, and delivery coordination. For organizations exploring Flurpiridaz (F18), it also means understanding availability, distribution, dosing schedules, and how tracer selection may affect daily workflows. Many organizations find the complexity of securing and managing radiopharmaceutical supply a major operational hurdle.
Overcoming this barrier requires early planning around radiopharmaceutical availability, scheduling models, and vendor coordination. Organizations need to understand not only what imaging agent they will use, but how that choice affects staffing, throughput, patient scheduling, and long-term program economics.
A successful Cardiac PET program requires a coordinated operational model that connects imaging technology, radiopharmaceutical access, and daily workflow execution.
What Staffing and Training Are Required for Cardiac PET?
Cardiac PET staffing is another common implementation concern. For organizations already facing workforce shortages, adding a new modality can raise difficult questions. Who will operate the scanner? Who will manage patient preparation? Who will support stress testing protocols? How much training will be required?
These concerns are especially important because Cardiac PET is not simply another imaging service. It requires specific workflow knowledge, clinical coordination, and operational discipline to run efficiently.
The solution is to address staffing early in the planning process. Programs should evaluate current team capacity, identify training needs, and create a realistic staffing model before launch.
With the right support, organizations can avoid placing the full burden of implementation on internal teams that may already be stretched.
Is Patient Volume Strong Enough to Support Cardiac PET?
Many decision-makers are unsure whether patient volume will support their program. This is especially true for programs that are transitioning from SPECT or evaluating Cardiac PET for the first time. SPECT may already be embedded in the workflow, and referring physicians may need education on which patients are appropriate for PET and how advanced imaging capabilities, such as myocardial blood flow assessment, may support improved diagnostic confidence in appropriate clinical circumstances.
Low initial volume does not always mean low long-term opportunity. In many cases, volume depends on clinical education, scheduling access, and confidence among ordering providers. To overcome this barrier, organizations should build a plan that includes internal education, physician engagement, and referral development.
The goal is not only to install technology, but to create a sustainable Cardiac PET program that can grow over time.
Does Your Organization Have the Space and Infrastructure to Support Cardiac PET?
Some organizations do not have an available room that can easily accommodate a PET/CT scanner. For hospitals with existing PET/CT scanners, cardiology may also compete with oncology for scanner time. Others may face challenges related to patient flow, accessibility, and regulatory requirements.
These limitations can make Cardiac PET feel out of reach for facilities that do not have an obvious location for a permanent suite. Flexible implementation models can help address this challenge. Mobile, fixed mobile, and custom suite pathways give organizations options based on available space, program maturity, and long-term goals.
Rather than forcing every organization into the same buildout model, the right pathway can help match Cardiac PET access to the realities of the facility.
How Will Your Organization Navigate Regulatory and Compliance Requirements?
Cardiac PET programs must operate within a regulated environment that may include radiation safety requirements, licensing, accreditation, documentation, quality control, reimbursement rules, and payer expectations. Organizations should evaluate applicable coverage, coding, documentation, medical necessity, and payer-specific requirements as part of program planning. Reimbursement availability and requirements may vary by payer, setting, indication, and jurisdiction.
For organizations that have not previously operated PET services, the regulatory path can feel especially complex. Even organizations with nuclear imaging experience may need additional support when evaluating PET-specific requirements.
A successful implementation process should help organizations identify requirements early and create workflows that support both clinical quality and operational compliance.
Quick Assessment: Is Cardiac PET Right for Your Organization?
In most cases, the challenge is not whether Cardiac PET has value. The challenge is how to implement it in a way that aligns with the organization's financial model, staffing resources, facility limitations, patient demand, and long-term growth strategy.
Are you looking to expand advanced cardiovascular imaging services?
Do you serve patients who may benefit from higher diagnostic accuracy, lower radiation exposure, or assessment of myocardial blood flow?
Are referring physicians asking about PET capabilities or more advanced imaging options?
Are SPECT scheduling limitations affecting patient access or delaying answers?
Would faster imaging, improved throughput, or greater operational efficiency support your program goals?
Are you evaluating future growth opportunities for your cardiovascular service line?
If you answered "yes" to any of these questions, Cardiac PET likely belongs in your planning conversation. The next step is to understand which implementation pathway fits your organization, starting with an honest assessment of your current readiness.
That is the problem that Cardiac PET 360 from CDL Nuclear Technologies was built to solve.
Cardiac PET 360 is CDL Nuclear Technologies' flexible approach to helping hospitals, health systems, and practices evaluate, launch, and grow Cardiac PET programs. Rather than offering a single implementation model, it provides flexible pathways and hands-on support across every stage, from financial planning and logistics to staffing, compliance, and referral development.
Through Cardiac PET 360, CDL Nuclear helps organizations address the major barriers that often slow adoption; however, with the right planning process, organizations can better understand what is required, what barriers need to be addressed, and which implementation model makes the most sense.
Learn more about Cardiac PET 360 and take the first step toward building a program that fits your organization's goals, resources, and timeline.
This content is provided for informational purposes only and does not constitute clinical, legal, financial, reimbursement, or regulatory advice. Organizations should consult qualified clinical, legal, reimbursement, regulatory, and financial advisors when evaluating Cardiac PET implementation.